High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells

被引:264
作者
Manavalan, JS [1 ]
Rossi, PC [1 ]
Vlad, G [1 ]
Piazza, F [1 ]
Yarilina, A [1 ]
Cortesini, R [1 ]
Mancini, D [1 ]
Suciu-Foca, N [1 ]
机构
[1] Columbia Univ, Dept Pathol & Internal Med, New York, NY 10032 USA
关键词
dendritic cells; T lymphocytes; cell surface molecules; tolerance/suppression/anergy; transplantation; REGULATORY T-CELLS; INHIBITORY RECEPTOR; 1-ALPHA; 25-DIHYDROXYVITAMIN D-3; TUMOR-IMMUNITY; INDUCTION; SUPPRESSION; TOLERANCE; DIFFERENTIATION; STIMULATION; MONOCYTES;
D O I
10.1016/S0966-3274(03)00058-3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The direct interaction between antigen specific CD8(+) CD28(-) T suppressor cells (T-s) with dendritic cells (DC) results in the tolerization of DC by inducing the upregulation of immunologlobulin like transcript 3 (ILT3) and ILT4. We show here that such tolerogenic DC anergize alloreactive CD4(+) CD45RO(+) CD25(+) T cells converting them into regulatory T cells (T-R), which in turn, continue the cascade of suppression by tolerizing other DC. Interleukin 10 (IL-10) and interferon-alpha (IFN-alpha) also induce ILT3 and ILT4 upregulation in DC, rendering them tolerogenic. This implies a common mechanism of DC-mediated suppression. This finding and the observation that in organ allograft recipients quiescence is associated with the presence in the circulation of donor-specific T, and T, emphasize the importance of the cross talk between tolerogenic DC and T cells in suppression of the immune response. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:245 / 258
页数:14
相关论文
共 33 条
[21]   1α,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation [J].
Penna, G ;
Adorini, L .
JOURNAL OF IMMUNOLOGY, 2000, 164 (05) :2405-2411
[22]   Immune inhibitory receptors [J].
Ravetch, JV ;
Lanier, LL .
SCIENCE, 2000, 290 (5489) :84-89
[23]   Cellular methods used to evaluate the immune response in transplantation [J].
Reinsmoen, NL .
TISSUE ANTIGENS, 2002, 59 (04) :241-250
[24]   Type 1 T regulatory cells [J].
Roncarolo, MG ;
Bacchetta, R ;
Bordignon, C ;
Narula, S ;
Levings, MK .
IMMUNOLOGICAL REVIEWS, 2001, 182 :68-79
[25]   Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells:: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance [J].
Sakaguchi, S ;
Sakaguchi, N ;
Shimizu, J ;
Yamazaki, S ;
Sakihama, T ;
Itoh, M ;
Kuniyasu, Y ;
Nomura, T ;
Toda, M ;
Takahashi, T .
IMMUNOLOGICAL REVIEWS, 2001, 182 :18-32
[26]   CD4+CD25+ suppressor T cells:: More questions than answers [J].
Shevach, EM .
NATURE REVIEWS IMMUNOLOGY, 2002, 2 (06) :389-400
[27]   Certified professionals:: CD4+CD25+ suppressor T cells [J].
Shevach, EM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 193 (11) :F41-F45
[28]  
Shimizu J, 1999, J IMMUNOL, V163, P5211
[29]   Stimulation of CD25+CD4+regulatory T cells through GITR breaks immunological self-tolerance [J].
Shimizu, J ;
Yamazaki, S ;
Takahashi, T ;
Ishida, Y ;
Sakaguchi, S .
NATURE IMMUNOLOGY, 2002, 3 (02) :135-142
[30]  
Steinbrink K, 1997, J IMMUNOL, V159, P4772